Navigation Links
Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Date:10/14/2010

WORCESTER, Mass., Oct. 14 /PRNewswire/ -- Generex Biotechnology Corporation (NasdaqCM: GNBT, www.generex.com) today announced that the sole matter for consideration by stockholders at the reconvened special meeting of stockholders being held tomorrow, October 15, 2010, will be to approve a proposal to adjourn the special meeting to Monday, October 18, 2010.

As previously disclosed in Generex's proxy statement dated August 23, 2010, Generex received a delisting determination letter from the staff of The Nasdaq Stock Market in May 2010 due to Generex's failure to regain compliance with The Nasdaq Capital Market's minimum bid price requirement for continued listing.  Generex appealed the determination, and the Nasdaq Hearings Panel granted Generex's request to remain listed on The Nasdaq Stock Market, subject to certain conditions, including obtaining shareholder approval on or before July 28, 2010 to implement a reverse stock split in a ratio sufficient to meet the $1.00 bid price requirement for continued listing.  At Generex's annual meeting held on July 28, 2010, the reverse stock split proposal was not approved because it fell short of the required threshold of at least 50% of the total shares outstanding voting in favor even though 60.62% of the voting stockholders voted in favor of the reverse stock split proposal.  Generex reported the results of the annual meeting to the Nasdaq Hearings Panel, and requested additional time to hold the special meeting dedicated to approving the reverse stock split.

On September 14, 2010, the Nasdaq Hearings Panel granted Generex's further request for continued listing, subject to certain conditions.  These conditions include informing the Panel that we have obtained shareholder approval to implement a reverse stock split in a ratio sufficient to meet the $1.00 bid price and demonstrating on or before November 2, 2010 a closing bid price of $1.00 o
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Generex Provides Clarification for Special Meeting Voting
2. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
3. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
4. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
5. Generex Presents Abstract at EASD Annual Meeting
6. Generex Announces Sales Agreement with Elias Shaker & Company
7. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
8. Generex Announces Presentations of Novel Vaccine Strategies
9. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
10. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
11. CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) ... 2014 ended July 31, 2014 on Monday, September 29 before ... the results at 11:00 AM ET. Participating in the call ... A. Krakauer , President and CEO; Jorgen B. Hansen ... , Senior Vice President, CFO and Treasurer; and Seth ...
(Date:9/22/2014)...  For many people experiencing issues with their ... prospect of large, painful incisions and long recovery ... also impacted, such as working, driving and even ... some patients even delay necessary treatment, resorting to ... permanent damage for some conditions. Logo ...
(Date:9/22/2014)... PLYMOUTH MEETING, Pa. , Sept. 22, 2014 ... ) announced today it has initiated a phase ... The trial will evaluate the safety, tolerability, and ... type 6 (HPV-6), which causes most aerodigestive cancers. ... tongue, nose, throat, vocal cords, and parts of ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4
... SPRING, Md., March 11 In a boost to,HIV ... provide a,royalty-free license to the non-profit International Partnership for,Microbicides ... as a,potential vaginal microbicide., The compound, called L,644, ... as gp41 fusion inhibitors, which inhibit HIV infection by,preventing ...
... data provides evidence for, potential benefit of starting Femara up to seven years after ... tamoxifen, ... published in Journal of Clinical Oncology, - Half of all breast cancer recurrences occur ... ...
Cached Medicine Technology:Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 2Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 2VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 4VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 5VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 6VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 7
(Date:9/22/2014)... Austin, Texas (PRWEB) September 22, 2014 ... testing and treatment, will work with companies to help ... prevent the development of diabetes as part of a ... Stop Diabetes @ Work initiative. , PreDiabetes Centers ... Texas Department of Transportation in Austin on Tuesday, October ...
(Date:9/22/2014)... Steven Reinberg HealthDay Reporter ... that bacterial pneumonia can raise your risk of heart problems, ... and kill heart cells, increasing the chances of heart failure, ... report. In mice, monkeys and human heart tissue, researchers ... and they tried a vaccine that might one day prevent ...
(Date:9/22/2014)... At the 10th Clinton Global ... Partnership (SNP) announced the successful launch of a ... Risk Reduction Program for Women. The announcement of ... their risk of heart disease through a seafood-rich ... for addressing significant global challenges made by CGI ...
(Date:9/22/2014)... Burbank, CA (PRWEB) September 22, 2014 ... social and mobile recruiting, announced today an ... talent management solutions for the healthcare industry. ... to TweetMyJobs’ suite of social recruiting solutions ... management software designed specifically for healthcare organizations. ...
(Date:9/22/2014)... -- In a collaboration that will encompass a ... and patient care and accelerate personalized genomic medicine, ... Medical Center (BIDMC) have established a new academic, ... today. , A recently signed agreement calls for ... a comprehensive relationship in the areas of research ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 3Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 2Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 4Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 2Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 3Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 4Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 2Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 3
... , TUESDAY, Aug. 9 (HealthDay News) -- Motion ... changing the way cars take curves, researchers say. They ... tilt only at the beginning and end of curves rather ... motion sickness. "This is a major breakthrough and a ...
... BOSTON Beth Israel Deaconess Medical Center (BIDMC) researchers ... been awarded Challenge Awards of $1 million each from ... teams of investigators in their pursuit of new treatments ... Awards will support a total of 10 scientific projects ...
... Concern about the capacity of individuals with schizophrenia to ... impairment due to psychotic symptoms associated with the disorder. ... that prospective participants make when undergoing a formal assessment ... in IRB: Ethics & Human Research ...
... 221.10.254.64 COLUMBIA, Mo. Due to changing guidelines ... screened for breast cancer with mammograms, many women are ... and older get a mammogram every year, but the ... year for women older than 50. A University of ...
... By Kathleen Doheny HealthDay Reporter , MONDAY, ... as a healthier alternative to estrogen for maintaining bone ... according to a new study. , "Our study shows ... not prevent bone loss or alleviate menopausal symptoms," said ...
... As parents prepare to send their children back to school, ... in academic performance, an expert advises. Studies have shown ... more alert throughout the school day and also earn higher ... Pat Alfaro, clinical manager of the division of nutrition therapy ...
Cached Medicine News:Health News:Going Full-Tilt Into Turns May Ease Motion Sickness on Trains 2Health News:BIDMC scientists receive Challenge Awards from Prostate Cancer Foundation 2Health News:Schizophrenia study finds cognitive deficits significantly impair decision-making capacity 2Health News:Doctors, women should spend more time discussing mammograms 2Health News:Soy Supplements Don't Ease Bone Loss, Menopausal Symptoms: Study 2Health News:Soy Supplements Don't Ease Bone Loss, Menopausal Symptoms: Study 3Health News:Healthy Lunch and Breakfast Keep Students Alert 2
... to 17 parameters from just 95 ... blood gases, as well as any ... metabolite parameters. Unique technology reduces to ... substances have on the accuracy of ...
... a sophisticated whole blood analysis system that ... also satisfying the stringent requirements of the ... contains all of the components of a ... the sampling unit, all of the sensors ...
... The Rapidlab 800 System is a ... key critical care whole blood parameters in ... modular design allows the basic blood gas ... to include electrolytes, metabolites and CO-oximetry in ...
This compact, easy-to-operate analyzer delivers basic blood gas, ISEs with direct measured total hemoglobin and saturated oxygen. Use it as a cost effective backup for the central lab or for remote p...
Medicine Products: